GOLDMAN SACHS GROUP INC Actuate Therapeutics, Inc. Common stock (ACTU) 13F holding

GOLDMAN SACHS GROUP INC reported 12,408 ACTU shares valued at $34.0M as of 2026-03-31 (CMN). Cached 13F row, not a live tape.

Not investment advice. Cached 13F row, not EDGAR XML.